These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

334 related items for PubMed ID: 31397092

  • 21. Development of a Molecular Assay for Detection and Quantification of the BRAF Variation in Residual Tissue From Thyroid Nodule Fine-Needle Aspiration Biopsy Specimens.
    Fu G, Chazen RS, MacMillan C, Witterick IJ.
    JAMA Netw Open; 2021 Oct 01; 4(10):e2127243. PubMed ID: 34613404
    [Abstract] [Full Text] [Related]

  • 22. [Clinical role of BRAF V600E mutation testing in thyroid nodules].
    Wan H, Zhang B, Wang Y, Xiao T, Guo H, Liu W, Yan D, Xu Z, Tang P.
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Jun 01; 49(6):468-72. PubMed ID: 25241863
    [Abstract] [Full Text] [Related]

  • 23. Cytomorphologic features in thyroid nodules read as "suspicious for malignancy" on cytology may predict thyroid cancers with the BRAF mutation.
    Kwon HJ, Kim EK, Kwak JY.
    Pathol Res Pract; 2015 Sep 01; 211(9):671-6. PubMed ID: 26187369
    [Abstract] [Full Text] [Related]

  • 24. BRAF mutation analysis by ARMS-PCR refines thyroid nodule management.
    Li X, Li E, Du J, Wang J, Zheng B.
    Clin Endocrinol (Oxf); 2019 Dec 01; 91(6):834-841. PubMed ID: 31441082
    [Abstract] [Full Text] [Related]

  • 25. Evaluation of the Clinical Usefulness of BRAFV600E Mutation Analysis of Core-Needle Biopsy Specimens in Thyroid Nodules with Previous Atypia of Undetermined Significance or Follicular Lesions of Undetermined Significance Results.
    Choi SH, Baek JH, Lee JH, Choi YJ, Song DE, Chung KW, Kim TY, Shong YK.
    Thyroid; 2015 Aug 01; 25(8):897-903. PubMed ID: 25978151
    [Abstract] [Full Text] [Related]

  • 26. Differential diagnosis of diffuse sclerotic thyroid papillary carcinoma and Hashimoto's thyroiditis using fine-needle aspiration cytology, BRAFV600E , and ultrasound elastography.
    Wang X, Xu F, Gao J, Agyekum EA, Sun H, Zhang G, Li X, Xiang H, Hu S, Qian X.
    J Clin Ultrasound; 2022 Sep 01; 50(7):942-950. PubMed ID: 35779272
    [Abstract] [Full Text] [Related]

  • 27. Contribution of the BRAF mutation analysis in calcified thyroid nodules.
    Yoo EY, Shin JH, Ko EY, Han BK.
    AJR Am J Roentgenol; 2012 Apr 01; 198(4):891-5. PubMed ID: 22451557
    [Abstract] [Full Text] [Related]

  • 28. What to do with thyroid nodules showing benign cytology and BRAF(V600E) mutation? A study based on clinical and radiologic features using a highly sensitive analytic method.
    Kim SY, Kim EK, Kwak JY, Moon HJ, Yoon JH.
    Surgery; 2015 Feb 01; 157(2):354-61. PubMed ID: 25616949
    [Abstract] [Full Text] [Related]

  • 29. BRAF V600E mutation and the Bethesda System for Reporting Thyroid Cytopathology of fine-needle aspiration biopsy for distinguishing benign from malignant thyroid nodules.
    Sheng D, Yu X, Li H, Zhang M, Chen J.
    Medicine (Baltimore); 2021 Sep 17; 100(37):e27167. PubMed ID: 34664843
    [Abstract] [Full Text] [Related]

  • 30. BRAFV600E mutation analysis in fine-needle aspiration cytology specimens for evaluation of thyroid nodule: a large series in a BRAFV600E-prevalent population.
    Kim SW, Lee JI, Kim JW, Ki CS, Oh YL, Choi YL, Shin JH, Kim HK, Jang HW, Chung JH.
    J Clin Endocrinol Metab; 2010 Aug 17; 95(8):3693-700. PubMed ID: 20501689
    [Abstract] [Full Text] [Related]

  • 31. The usefulness of determining the presence of BRAF V600E mutation in fine-needle aspiration cytology in indeterminate cytological results.
    Kowalska A, Kowalik A, Pałyga I, Walczyk A, Gąsior-Perczak D, Kopczyński J, Lizis-Kolus K, Szyska-Skrobot D, Hurej S, Radowicz-Chil A, Chodurska R, Wypiórkiewicz E, Chłopek M, Nowak E, Niemyska K, Góźdź S.
    Endokrynol Pol; 2016 Aug 17; 67(1):41-7. PubMed ID: 26884114
    [Abstract] [Full Text] [Related]

  • 32. The BRAF(V600E) mutation is associated with malignant ultrasonographic features in thyroid nodules.
    Lee EJ, Song KH, Kim DL, Jang YM, Hwang TS, Kim SK.
    Clin Endocrinol (Oxf); 2011 Dec 17; 75(6):844-50. PubMed ID: 21707687
    [Abstract] [Full Text] [Related]

  • 33. RAS mutations in indeterminate thyroid nodules are predictive of the follicular variant of papillary thyroid carcinoma.
    An JH, Song KH, Kim SK, Park KS, Yoo YB, Yang JH, Hwang TS, Kim DL.
    Clin Endocrinol (Oxf); 2015 May 17; 82(5):760-6. PubMed ID: 25109485
    [Abstract] [Full Text] [Related]

  • 34. Role of ultrasonographic/clinical profile, cytology, and BRAF V600E mutation evaluation in thyroid nodule screening for malignancy: a prospective study.
    Rossi M, Buratto M, Bruni S, Filieri C, Tagliati F, Trasforini G, Rossi R, Beccati MD, Degli Uberti EC, Zatelli MC.
    J Clin Endocrinol Metab; 2012 Jul 17; 97(7):2354-61. PubMed ID: 22535974
    [Abstract] [Full Text] [Related]

  • 35. BRAFV600E mutation testing in fine needle aspirates of thyroid nodules: potential value of real-time PCR.
    Kwak JY, Han KH, Yoon JH, Kim EK, Moon HJ, Kim YL, Park SJ, Choi JR.
    Ann Clin Lab Sci; 2012 Jul 17; 42(3):258-65. PubMed ID: 22964613
    [Abstract] [Full Text] [Related]

  • 36. Highly Sensitive and Specific Molecular Test for Mutations in the Diagnosis of Thyroid Nodules: A Prospective Study of BRAF-Prevalent Population.
    Cho YY, Park SY, Shin JH, Oh YL, Choe JH, Kim JH, Kim JS, Yim HS, Kim YL, Ki CS, Kim TH, Chung JH, Kim SW.
    Int J Mol Sci; 2020 Aug 06; 21(16):. PubMed ID: 32781560
    [Abstract] [Full Text] [Related]

  • 37. Surgical results of thyroid nodules according to a management guideline based on the BRAF(V600E) mutation status.
    Kim SK, Hwang TS, Yoo YB, Han HS, Kim DL, Song KH, Lim SD, Kim WS, Paik NS.
    J Clin Endocrinol Metab; 2011 Mar 06; 96(3):658-64. PubMed ID: 21239517
    [Abstract] [Full Text] [Related]

  • 38. Diagnostic value of BRAF(V600E) mutation analysis of thyroid nodules according to ultrasonographic features and the time of aspiration.
    Moon HJ, Kim EK, Chung WY, Choi JR, Yoon JH, Kwak JY.
    Ann Surg Oncol; 2011 Mar 06; 18(3):792-9. PubMed ID: 20945104
    [Abstract] [Full Text] [Related]

  • 39. Value of TIRADS, BSRTC and FNA-BRAF V600E mutation analysis in differentiating high-risk thyroid nodules.
    Zhang YZ, Xu T, Cui D, Li X, Yao Q, Gong HY, Liu XY, Chen HH, Jiang L, Ye XH, Zhang ZH, Shen MP, Duan Y, Yang T, Wu XH.
    Sci Rep; 2015 Nov 24; 5():16927. PubMed ID: 26597052
    [Abstract] [Full Text] [Related]

  • 40. BRAF(V600E) mutation analysis of liquid-based preparation-processed fine needle aspiration sample improves the diagnostic rate of papillary thyroid carcinoma.
    Chang H, Lee H, Yoon SO, Kim H, Kim A, Kim BH.
    Hum Pathol; 2012 Jan 24; 43(1):89-95. PubMed ID: 21774961
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.